| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.2M | — | -18.1% |
| R&D Expense | $57.8M | — | +23.5% |
| SG&A Expense | $13.5M | — | +33.3% |
| Operating Income | -$64.1M | — | -33.1% |
| Pre-tax Income | -$61.7M | — | -39.4% |
| Income Tax | $28K | — | -50.0% |
| Net Income | -$61.4M | — | -47.4% |
| EPS (Basic) | -$1.07 | — | +34.0% |
| EPS (Diluted) | -$1.07 | — | +34.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $160.6M | +32.0% | -27.2% |
| Short-term Investments | $356.1M | +256.6% | — |
| Current Assets | $535.4M | +128.4% | — |
| Total Assets | $625.7M | +89.5% | — |
| Current Liabilities | $58.4M | -29.0% | — |
| Total Liabilities | $110.9M | -21.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$80.4M | — | -51.2% |
| Capital Expenditures | $3.8M | — | +403.5% |
| Investing Cash Flow | -$259.9M | — | -444.1% |
| Financing Cash Flow | $378.9M | — | +1742.9% |
| Free Cash Flow | -$84.2M | — | -56.1% |
| — |
| Stockholders' Equity | $514.8M | +183.6% | +209.3% |